Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
00:00
CD20 x CD3 Bispecific Antibodies in Non-Hodgkin Lymphoma Management
This chapter discusses the role of CD20 x CD3 bispecific antibodies in the management of Non-Hodgkin Lymphoma, including education and support provided by companies, guidelines developed by the Lymphoma Research Foundation, sequencing of therapy for FL, measuring CD20 expression, and potential cytokine release syndrome.
Transcript
Play full episode
